CDC Recommends Pfizer And Moderna Vaccines Over Johnson & Johnson Due To Rare Blood Clotting Issue

The CDC now recommends that Americans take the mRNA vaccines made by Pfizer and Moderna instead of the one-shot Johnson & Johnson vaccine due to rare but serious blood clots.

The agency’s Advisory Committee on Immunization Practices unanimously voted on Thursday to give a preferential recommendation to Moderna and Pfizer’s shots. 

“More than 200 million Americans have completed their primary vaccine series, providing protection against COVID-19, preventing millions of cases and hospitalizations, and saving over a million lives,” CDC Director Rochelle Walensky said in a statement. “Today’s updated recommendation emphasizes CDC’s commitment to provide real-time scientific information to the American public.”

The CDC temporarily halted Johnson & Johnson’s vaccine in April while scientists investigated the blood clots, which are known as “thrombosis with thrombocytopenia syndrome.”

Regulators eventually decided that the benefits of the Johnson & Johnson vaccine outweighed the risks, but the FDA released new data this week showing that more cases have occurred in the summer and fall. 

Women between the ages of 30 and 49 are most affected by the blood clotting issue at a rate of about 1 in 100,000 shots. 

Continue reading https://www.foxbusiness.com/economy/cdc-advisory-panel-recommends-pfizer-and-modern-vaccines-over-johnson-johnson

Get Citizensjournal.us Headlines free  SUBSCRIPTION. Keep us publishing – DONATE